S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
What recession? Professional forecasters raise expectations for US economy in 2024
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
What recession? Professional forecasters raise expectations for US economy in 2024
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
What recession? Professional forecasters raise expectations for US economy in 2024
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high
S&P 500   5,088.80
DOW   39,131.53
QQQ   436.78
How this AP photographer captured a unique splash at the swimming worlds with an underwater camera
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
Tax-free status of movie, music and games traded online is on table as WTO nations meet in Abu Dhabi
Delays in promised Western military aid to Ukraine are costing lives, the defense minister says
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
MILAN FASHION PHOTOS: Feben, Rave Review promote looks for women of all shapes, ages and sizes
Caribbean leaders meet with Haiti's prime minister. Foreign force deployment is on the agenda
Investing Wizard Who Turned $37K Into $2.7M in Just 4 Years Makes His Next Big Move (Ad)
What recession? Professional forecasters raise expectations for US economy in 2024
Stock market today: Asian shares mostly decline, while Tokyo again touches a record high

3 stocking stuffers you can buy for yourself

Stocks to buy

Key Points

  • Bristol-Meyers Squibb is a deep-value, high-yield name in pharma trading near its floor.
  • The S.J. Smucker Company is a sweet treat for dividend growth investors and a value for income investors. 
  • Investar is trading below the analyst's lowest target, paying 3.85% with a low beta to help offset market volatility. 
  • 5 stocks we like better than Bristol-Myers Squibb

Stocking stuffers are small, inexpensive presents that help to complete the holiday, so for this screen, the focus was on inexpensive stocks. Inexpensive means a low P/E multiple relative to the S&P 500 NYSEARCA: SPY, but it doesn’t mean cheap. Each stock on this list is a quality dividend-paying name with a higher-than-average yield to help brighten the season (and portfolio returns). Additionally, the screen criteria include a low beta and stocks trading near their 52-week low to try and capture a bit of sleep-soundly-at-night safety to help offset any worry for the coming year. 

Bristol-Myers Squibb and the patent cliff

Bristol-Myers Squibb NYSE: BMY is struggling with the patent cliff like most other big pharma companies, depressing the market. However, the takeaway from the data suggests the market is oversold and trading near its floor, setting up for a rebound in 2024. While 2023 results show YOY decline, the decline is narrowing sequentially, and growth is expected to return next year. 

Regarding the stock screen and metrics, BMY stock is at the top of the list with a low 6.5X valuation, well below its peers, and it pays a solid 4.65%. The dividend is reliably safe for 2024 and can be expected to grow. The yield is compounded by a super-low 0.30 beta, which suggests little to no movement compared to the S&P, and the stock is already trading at its floor. 

Analyst's sentiment aided the decline in share prices, but the move has run its course. While analysts have steadily lowered their price targets in 2023, the sentiment has held firm at Hold, and the low end of the range coincides with critical market support. That level is $50, consistent with the COVID-19 lows set in 2020 and a launch pad for higher prices. Among the catalysts for growth is the acquisition of Mirati Therapeutics and its oncology drug, Krazati.

BMY stock charts

The J.M. Smucker Company is a sweet treat

The J.M. Smucker Company NYSE: SJM shares are in deep value territory in more ways than one. Not only does the stock trade near 12X earnings, near the low-end for blue chip consumer staples companies, but it trades about 1000 basis points below the lowest analyst target, which was very recently set. In this scenario, the market is set up to rebound solidly in 2024 because growth is expected to resume. The consensus target for next year is for revenue and earnings to be up 12%, sufficient to sustain the outlook for dividend increases. 

SJM stock pays about 3.8%, trading near 12X earnings and only pays 45% of earnings. This leaves ample room on the books to continue with annual increases which already top 25 years. The analysts have helped the stock to fall to its current levels with a series of price target reductions. 

However, the analysts have recently upped the consensus sentiment to Hold and see it trading about 30% higher at the consensus price target. The next catalyst will be the FQ2 earnings in early December. The analysts expect a YOY revenue decline but for the margin to expand, and the bar is set low for both. 

SJM stock charts

Investar Holding Corporation Rising; Oversold and overextended value play

Investar Holding Corporation NASDAQ: ISTR is the holding corporation for Investar Bank, operating in Southern Louisiana. The share prices are depressed for several reasons, including the bank crisis early in 2023, tepid growth, and its relatively unknown status. However, trading at 5X earnings and paying 3.85% is worth a nibble due to its low 0.20 beta and even lower 18% payout ratio. 

Marketbeat tracks 2 analysts with current ratings in 2023, both set since the middle of the year. They rate the stock at Moderate Buy and see it trading well below its target range. A move to the analysts' low target is worth more than 30%, and the consensus figure adds a few hundred basis points. 

The chart is promising. Although trading at a long-term low, the indicators show the market diverges from its trend and is set up to rebound. The MACD and stochastic are already firing a bullish signal, so this market could see a substantial rally before the end of the year. 

ISTR stock charts

→ Elon Musk's "Project Dojo" is a Game-Changer (From Stansberry Research) (Ad)

Should you invest $1,000 in Bristol-Myers Squibb right now?

Before you consider Bristol-Myers Squibb, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bristol-Myers Squibb wasn't on the list.

While Bristol-Myers Squibb currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Investar (ISTR)
4.5765 of 5 stars
$16.38-0.7%2.44%9.69Moderate Buy$14.13
J. M. Smucker (SJM)
4.2917 of 5 stars
$125.92+1.3%3.37%-2,098.67Hold$138.07
Bristol-Myers Squibb (BMY)
4.8281 of 5 stars
$51.66+0.6%4.65%13.38Hold$61.17
Compare These Stocks  Add These Stocks to My Watchlist 

Thomas Hughes

About Thomas Hughes

  • tmhughes.writeon@gmail.com

Contributing Author

Technical and Fundamental Analysis

Experience

Thomas Hughes has been a contributing writer for MarketBeat since 2019.

Areas of Expertise

Technical analysis, the S&P 500; retail, consumer, consumer staples, dividends, high-yield, small caps, technology, economic data, oil, cryptocurrencies

Education

Associate of Arts in Culinary Technology

Past Experience

Market watcher, trader and investor for numerous websites. Founded Passive Market Intelligence LLC to provide market research insights. 


Featured Articles and Offers

Search Headlines: